2 research outputs found
Anti-proliferative effects of salmon calcitonin on SH-SY5Y neuroblastoma in vitro
Aim: We aimed to examine the potential cytotoxic effect of salmon calcitonin, which is one of the components that regulates mineral metabolism and prevents the increase in the amount of calcium, on SH-SY5Y cells, a neuroblastoma cell line.
Methods: SH-SY5Y cells were cultured in DMEM medium in the presence of 37°C and 5% CO2 in conventional culture flasks. MTT assay was applied to investigate the effect of calcitonin individually on SH-SY5Y cells by treatment different concentrations for 24 h and performed.
Results: In cells cultured with salmon calcitonin applied at different concentrations (0.1, 1, 3.125, 6,25, 12.5, 25, 50 and 100 nM/ml), anti-proliferation was statistically significant at concentrations of 50 and 100 nM/ml compared to the control group. It showed that 50 nM/ml and 100 nM/ml had the highest cytotoxic effect on SH-SY5Y for 24 h
Conclusions: Considering the proliferation curve of SH-SY5Y, the results show that salmon calcitonin treatment potentiated the proliferative activities by inhibiting cell viability in SH-SY5Y cells at concentrations of 50 and 100 nM/ml. Further studies exploring salmon calcitonin’s protective effects may prove successful and maybe it is a promising agent for cancer treatment
Evaluation of the resistance patterns of Mycobacterium tuberculosis complex strains to antituberculous drugs
Aim: To determine the resistance profile of Mycobacterium tuberculosis complex (MTBC) strains to first-line antituberculous drugs.
Methods: A total of 138 patients with MTBC growth from 2008-2018 were evaluated retrospectively. The Ehrlich-Ziehl-Neelsen (EZN) staining method was used for direct smear preparations, the BACTEC MGIT 460 TB system the Lowenstein-Jensen medium for culture planting and the BACTEC NAP test for the diagnosis of MTBC. Susceptibility tests were performed using the BACTEC MGIT 460 TB system with the streptomycin, isoniazid, rifampicin and ethambutol (SIRE) kit in accordance with the manufacturer's recommendations.
Results: Of the total 138 tuberculosis (TB) cases, 44 (31.9%) were female and 94 (68.1%) were male. MTBC was most frequently isolated from pulmonary specimens (90.6%). Acid-resistant bacilli (ARB) positivity was detected in 88 (63.8%) samples by EZN staining for culture-positive samples. In our study, without considering single or multiple drug resistance (MDR), total resistance rates in MTBC strains were determined for, isoniazid (INH), rifampicin (RIF), ethambutol (EMB), and streptomycin (SM); 10.1%, 4.3%, 2.9%, and 12.3% respectively. While the susceptibility to all drugs was 82.6%, multiple drug–resistant tuberculosis (MDR-TB) was 2.9%.
Conclusion: These results are important since they are the first data reported from our province regarding the determination of the resistance profile to anti-TB drugs. Resistance rates in our study were very close to the 2016 data average of the Ministry of Health of Turkey. Determination of TB resistance profiles, as well as proper and regular treatment, will contribute to the control of MDR-TB